Physician profile
Raymond Tien
NPI 1073518551
$1,167.17
in general payments reported to CMS, 2019-2025
21 companies · $37.88 in 2025
The $37.88 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $285 · 2021: $203 · 2022: $80.00 · 2023: $164 · 2024: $33.42 · 2025: $37.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $173.04 | 2019-2024 | Senza |
| Depuy Synthes Sales INC. | $134.94 | 2020-2023 | Embotrap |
| Medtronic, INC. | $131.78 | 2021-2023 | Aquamantys(Tm) |
| Globus Medical, INC. | $107.73 | 2019-2021 | |
| Medtronic USA, INC. | $96.35 | 2019-2020 | |
| Stryker Corporation | $92.33 | 2019-2021 | |
| Microvention, INC. | $55.46 | 2021 | |
| Amgen INC. | $52.56 | 2019 | |
| Boston Scientific Corporation | $44.18 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Brainlab, INC. | $37.14 | 2023 | Image Guided Surgical Device |
| Baxter Healthcare | $32.20 | 2019 | |
| Ferring Pharmaceuticals INC. | $32.04 | 2019-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $29.65 | 2019-2020 | |
| Si-Bone, INC. | $29.29 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $21.48 | 2025 | Dysport |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $19.70 | 2020 | |
| Piramal Critical Care | $16.94 | 2023 | |
| Kci USA, INC. | $16.67 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.40 | 2025 | |
| Stratus Medical, LLC | $13.67 | 2023 | Nimbus |
| Arbor Pharmaceuticals, INC. | $13.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Tien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.